证券记录 · 已归档季度
IMVT
Immunovant, Inc. · Healthcare · Biotechnology
11被追踪持有人
—Δ持有人
7.29M持有股份
$192.47M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 92 | +8 | 58.13M | $2.24B | +14 | −5 |
| Q1 2026 | 86 | +8 | 53.00M | $1.32B | +12 | −4 |
| Q4 2025 | 78 | -2 | 55.44M | $1.41B | — | −2 |
| Q3 2025 | 16 | 0 | 40.91M | $659.48M | +1 | −2 |
| Q2 2025 | 14 | -2 | 41.55M | $664.87M | — | −2 |
| Q1 2025 | 13 | +2 | 9.17M | $156.74M | +2 | — |
| Q4 2024 | 11 | -2 | 8.24M | $204.11M | — | −2 |
| Q3 2024 | 12 | +1 | 7.03M | $200.30M | +1 | — |
| Q2 2024 | 11 | — | 7.29M | $192.47M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 2.32M | — | $61.27M | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.41M | — | $37.34M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.41M | — | $37.34M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.36M | — | $35.95M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.36M | — | $35.95M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 601.86K | — | $15.89M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 420.00K | — | $11.09M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 388.10K | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 343.51K | — | $9.07M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 343.51K | — | $9.07M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 275.35K | — | $7.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 86.28K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 86.28K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 86.28K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 41.48K | — | $1.10M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 41.48K | — | $1.10M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 36.93K | — | $974,925 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 36.93K | — | $974,925 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 36.93K | — | $974,925 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 36.93K | — | $974,925 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 215 持有人, 110.50M 股份, $2.64B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 20
Gloria Melanie
Officer · 3.06K 股 · $134,953
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — Deep Track Capital, LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据